arrow
M

Mario Habek

referral center for autonomic nervous system disorders
H指数:33
被引数:4,454

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multiple sclerosis outcomes after cancer diagnosis in people with recorded chemotherapy exposure: A real-world MSBase study

在记录有化疗暴露的人群中,癌症诊断后的多发性硬化结局:一项真实世界MSBase研究

2026-08-020
PRE
Treatment escalation after clinically silent MRI lesions in relapsing-remitting multiple sclerosis

在复发缓解型多发性硬化中,针对临床静息期MRI病灶的治疗升级

Brain
IF11.7
2026-07-240
OAAI
Causal effects of multiple sclerosis therapies in left-truncated registry data

多发性硬化疗法在左截断登记数据中的因果效应

2026-07-210
PRE
Long-term outcomes of cladribine tablets in multiple sclerosis: Treatment completion, persistence, and subsequent therapy transitions in Southeast Europe

氯达拉滨片剂在多发性硬化症中的长期疗效:东南欧地区的治疗完成率、持续性和后续治疗方案转换

2026-05-010
PRE
Predicting disease progression in multiple sclerosis with clinically accessible information and technology

利用临床可获取的信息和技术预测多发性硬化症的疾病进展

2026-04-190
OAAI
Setting up an autonomic unit within the neurological department: a position statement of the European Federation of Autonomic Societies

在神经内科部门设立自主神经单元:欧洲自主神经学会联合会的立场声明

2026-02-100
OAAI
Real-world effectiveness and safety of ofatumumab in relapsing multiple sclerosis: A multicenter cohort study
2026-01-130
PRE
The impact of national policies on reimbursement of disease-modifying therapies for multiple sclerosis on disease outcomes: Slovenia versus Croatia

国家政策对多发性硬化症疾病修正治疗药物报销及其疾病结局的影响:斯洛文尼亚与克罗地亚比较

2025-09-180
PRE